According to WiseGuy Reports, the Reserpine Market is expected to grow from USD 1.57 billion in 2024 to USD 2.01 billion by 2032, registering a CAGR of 3.17% during the forecast period. Increasing prevalence of hypertension, rising cardiovascular disease cases, expanding healthcare infrastructure, and favorable government initiatives promoting cardiovascular health are contributing to stable...